/Investor DB

DCVC (Data Collective) — 2020 Investments

7 investments dated 2020 · listed companies and verified rows first · show all

Recursion Pharmaceuticalsrecursion.comin𝕏NASDAQ: RXRXSeries A · Nov 2020 · $13M✓ verified

Recursion applies computational and data-driven approaches to biological science, aiming to accelerate drug discovery and develop new treatments.

AI & Machine LearningBiotechData & InfrastructureDeep TechMedical DevicesSalt Lake City, US

Chris Gibson(Co-founder and Chairman of the Board)inBlake C. Borgeson(Executive Officer, Director)inDean Y. Yi(Executive Officer, Director)Najat Khan(Chief Executive Officer)inNajat Khan, Ph.D.(CEO and President)inBlake Borgeson(Founder)

Board seatZachary Bogue· per SEC Form D

Co-investorsLux CapitalBaillie GiffordAdvantage Capital PartnersAir Street CapitalAmplify PartnersCatalio Capital Management, LP+22 more

Propriopropriovision.comin𝕏Series A · Jun 2020 · $23M✓ verified

Proprio develops Paradigm, an implant-agnostic surgical platform that provides intraoperative guidance and structured surgical data without requiring 3D imaging or mobile CT.

AI & Machine LearningHealthtechMedical DevicesSeattle, US

Gabriel Jones(Co-founder & CEO)inSamuel Browd(Co-founder)inJoshua Smith(Co-founder)inJames Youngquist(Co-founder)in

Co-investorsBold Capital PartnersCota CapitalBird B. AGHTCPresence CapitalBOLD Longevity+4 more

Lumafieldlumafield.comin𝕏Series A · Jan 2020

Lumafield builds industrial X-ray CT scanning hardware and cloud-connected analysis software that let engineering, R&D, and production teams inspect the interior of manufactured parts for defects and dimensional accuracy.

Advanced ManufacturingAI & Machine LearningDeep TechHardwareSan Francisco, US

Eduardo Torrealba(Founder)inAndreas Bastian(Founder)inJonathan Aharon(Founder)inScott Johnston(Founder)inKevin Cedrone(Founder)Ric Fulop(Founder)

Co-investorsAlumni VenturesBasecamp FundG2 Venture PartnersIVP (Institutional Venture Partners)Kleiner PerkinsLAUNCH+7 more

Molecular Assembliesmolecularassemblies.comJul 2020

Molecular Assemblies uses a Fully Enzymatic Synthesis (FES) technology to produce long, pure, and accurate synthetic DNA oligonucleotides, up to 400 bases, without post-synthesis purification.

BiotechDeep TechNew MaterialsSan Diego, US

J. William Efcavitch, Ph.D.(Treasurer and Chief Scientific Officer)Michael J. Kamdar(President, Chief Executive Officer and Secretary)Bill Efcavitch(Founder)Curt Becker(Founder)

BoardDavid Hwang(Director)Larry Stambaugh(Chairman of the Board of Directors)

Co-investors11.2 CapitaliSelect FundKeshif VenturesRising TideAlexandriaArgonautic Ventures+2 more

Novome Biotechnologiesnovomebio.comSeries A · Jan 2020 · $33M

South San Francisco biotech engineering commensal gut bacteria into controllable live therapeutics for chronic diseases.

Daly City, US

Weston Whitaker(Executive Officer, Director, Promoter)William DeLoache(Director)Samuel Smits(Director)

BoardElizabeth Stanley(Director)

Co-investorsAlta PartnersCerity Partners VenturesColorcon Ventures5AM VenturesAlexandriaDCVC Bio+2 more

nTopologyntop.comin𝕏Sep 2020 · $40M

nTop provides a software platform for engineering design that uses implicit modeling and physics-based simulation to accelerate product development.

Advanced ManufacturingAI & Machine LearningDeep TechDeveloper ToolsEnterprise SoftwareSaaSNYC, US

Gregory Schroy(Executive Officer, Director, Promoter)Bradley Rothenberg(Founder)in

Co-investorsCanaan PartnersIn-Q-TelNimble PartnersNotation CapitalNVIDIAPathbreaker Ventures+8 more

Subtlesubtle.coin𝕏Nov 2020 · $12.2M

Subtle Computing (legally Skywalk, Inc.) makes wireless earbuds sold directly at subtle.co and through authorized resellers, along with a companion mobile app.

AI & Machine LearningConsumerDirect to ConsumerHardware

Tyler Chen(Founder)inDavid Harrison(Founder)Jackie Yang(Founder)Savannah Cofer(Founder)

Co-investorsAbstract VenturesEntrada VenturesInception Studio CapitalSLVCSurgePoint Angel3E Bioventures Capital+10 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.